Adenosine receptor ligands-recent developments Part I. AgonistsMÜLLER, C. E.Current medicinal chemistry. 2000, Vol 7, Num 12, pp 1269-1288, issn 0929-8673Article

General synthesis and properties of 1-monosubstituted xanthinesMÜLLER, C. E.Synthesis (Stuttgart). 1993, Num 1, pp 125-128, issn 0039-7881Article

Formation of oxazolo[3,2-a]purinones from propynyluracilsMÜLLER, C. E.Journal of organic chemistry. 1994, Vol 59, Num 7, pp 1928-1929, issn 0022-3263Article

A_2A-Selective adenosine receptor antagonists : Development of water-soluble prodrugs and a new tritiated radioligandMÜLLER, C. E; SAUER, R; MAURINSH, Y et al.Drug development research. 1998, Vol 45, Num 3-4, pp 190-197, issn 0272-4391Conference Paper

Configurationally stable analogs of styrylxanthines as A_2A adenosine receptor antagonistsMÜLLER, C. E; SCHOBERT, U; HIPP, J et al.European journal of medicinal chemistry. 1997, Vol 32, Num 9, pp 709-719, issn 0223-5234Article

Lipophilic disulfide prodrugs ― syntheses and disulfide bond cleavageMÜLLER, C. E; DANIEL, P. T; HOLZSCHUH, J et al.International journal of pharmaceutics. 1989, Vol 57, Num 1, pp 41-47, issn 0378-5173Article

Adenosine A_2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillationBATALHA, V. L; PEGO, J. M; FONTINHA, B. M et al.Molecular psychiatry. 2013, Vol 18, Num 3, pp 320-331, issn 1359-4184, 12 p.Article

Preference of horses for grass conserved as hay, haylage or silageMÜLLER, C. E; UDEN, P.Animal feed science and technology. 2007, Vol 132, Num 1-2, pp 66-78, issn 0377-8401, 13 p.Article

Immobilization, a risk factor for urinary tract stones in children. A case reportMÜLLER, C. E; BIANCHETTI, M; KAISER, G et al.European journal of pediatric surgery. 1994, Vol 4, Num 4, pp 201-204, issn 0939-7248Conference Paper

Methylxanthines block antigen-induced responses in RBL-2H3 cells independently of adenosine receptors or cyclic AMP : evidence for inhibition of antigen binding to IgEALI, H; MÜLLER, C. E; DALY, J. W et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 258, Num 3, pp 954-962, issn 0022-3565Article

Synthese computergraphik berechneter high-anti-fixterter Pyrimidin-Nucleosid-Analoga mit potentieller virostatischer und antineoplastischer wirksamkeit = Synthèse d'analogues de pyrimidine nucléosides, modélisés par ordinateur, dont la majorité est fixée de manière anti et possédant des activités virostatique et anticancéreuse potentielles = Synthesis of computer-modelled high-anti-fixed pyrimidine-nucleoside-analogues with potential virostatic and antineoplastic activitiesFOLKERS, G; JUNGINGER, G; MÜLLER, C. E et al.Archiv der Pharmazie (Weinheim). 1989, Vol 322, Num 2, pp 119-123, issn 0365-6233Article

Crystal structure of 8-(5-bromopentyl)-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a, 4a-diaza-s-indacene, C₁₈H₂₄BBrF₂N₂EULER, H; KIRFEL, A; FREUDENTHAL, S. J et al.Zeitschrift für Kristallographie. New crystal structures. 2002, Vol 217, Num 4, pp 543-545, issn 1433-7266, 3 p.Article

Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A_2A-Selective adenosine receptor antagonistsSAUER, R; MAURINSH, J; REITH, U et al.Journal of medicinal chemistry (Print). 2000, Vol 43, Num 3, pp 440-448, issn 0022-2623Article

Crystal structure of 5-ethyl-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-2,4(3H)-pyrimidinedione, C₃₂H₂₈N₂O₉KNOBLAUCH, B. H. A; KÖSTER, U; MÜLLER, C. E et al.Zeitschrift für Kristallographie. New crystal structures. 1998, Vol 213, Num 1, pp 143-144, issn 1433-7266Article

Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A_2A-selective adenosine receptor antagonistsMÜLLER, C. E; GEIS, U; HIPP, J et al.Journal of medicinal chemistry (Print). 1997, Vol 40, Num 26, pp 4396-4405, issn 0022-2623Article

Adenosine receptors and their modulatorsMÜLLER, C. E; SCIOR, T.Pharmaceutica Acta Helvetiae. 1993, Vol 68, Num 2, pp 77-111, issn 0031-6865Article

Stimulation of calcium release by caffeine analogs in pheochromocytoma cellsMÜLLER, C. E; DALY, J. W.Biochemical pharmacology. 1993, Vol 46, Num 10, pp 1825-1829, issn 0006-2952Article

THE VESICULAR MONOAMINE TRANSPORTER (VMAT-2) INHIBITOR TETRABENAZINE INDUCES TREMULOUS JAW MOVEMENTS IN RODENTS: IMPLICATIONS FOR PHARMACOLOGICAL MODELS OF PARKINSONIAN TREMORPODURGIEL, S. J; NUNES, E. J; LENDENT, C et al.Neuroscience. 2013, Vol 250, pp 507-519, issn 0306-4522, 13 p.Article

Chlamydia pneumoniae carriage and infection in hospitalized children with respiratory tract diseasesSCHMIDT, S. M; MÜLLER, C. E; KRECHTING, M et al.Infection. 2003, Vol 31, Num 6, pp 410-416, issn 0300-8126, 7 p.Article

Clinical presentations of infection by the human herpesvirus-7 (HHV-7)BRUNS, R; MÜLLER, C. E; WIERSBITZKV, S. K. W et al.Pediatric hematology and oncology. 2000, Vol 17, Num 3, pp 247-252, issn 0888-0018Article

Aza-analogs of 8-styrylxanthines as A_2A-Adenosine receptor antagonistsMÜLLER, C. E; SAUER, R; GEIS, U et al.Archiv der Pharmazie (Weinheim). 1997, Vol 330, Num 6, pp 181-189, issn 0365-6233Article

Uridine nucleotide receptors and their ligands : Structural, physiological, and pathophysiological aspects, with special emphasis on the nervous systemHEILBRONN, E; KNOBLAUCH, B. H. A; MÜLLER, C. E et al.Neurochemical research. 1997, Vol 22, Num 8, pp 1041-1050, issn 0364-3190Article

Tricyclic theophylline derivatives with high water-solubility : structure-activity relationships at adenosine receptors, phosphodiesterases, and benzodiazepine binding sitesGEIS, U; GRAHNER, B; PAWŁOWSKI, M et al.Pharmazie. 1995, Vol 50, Num 5, pp 333-336, issn 0031-7144Article

Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position : structure-activity relationships at adenosine receptorsMÜLLER, C. E; DAN SHI; MANNING, M. JR et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 22, pp 3341-3349, issn 0022-2623Article

Page / 2